GLP accreditation for Venus Research Centre

Terming it as a landmark achievement,Dr Manu Chaudhary,Joint Managing Director,Venus Remedies Limited,and Director,Research,VMRC,said,This GLP accreditation,one of the most coveted certifications for R&D capabilities,is yet another significant milestone in our efforts to ensure product quality,safety,reliability and excellence while preserving and improving human life through innovation.

The certification is an attestation of the consistent reliability of the company’s R&D tests and calibration as well as its documented quality management system. Besides this,the GLP certification meets the company’s strategic vision to bring to the world novel breakthroughs that cater to critical care and super-specialty segments,including anti-infective (anti-microbial resistance),anti-cancer,neurology,pain management and wound care.

Given the cut-throat competition among pharmaceutical companies,this GLP accreditation will provide an edge to Venus Remedies Limited. The company has a robust pipeline of research products. Many of these products are out-licensed and many others have already been approved in regulated and emerging markets.